• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病初级保健患者的人口统计学、疾病相关和治疗途径相关变量与健康相关生活质量之间的关联。

Associations between demographic, disease related, and treatment pathway related variables and health related quality of life in primary care patients with coronary heart disease.

机构信息

Department of General Practice/Family Medicine, Philipps University of Marburg, Karl-von-Frisch-Strasse 4, 35043, Marburg, Germany.

出版信息

Health Qual Life Outcomes. 2012 Jul 9;10:78. doi: 10.1186/1477-7525-10-78.

DOI:10.1186/1477-7525-10-78
PMID:22776102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3464887/
Abstract

BACKGROUND

Coronary heart disease (CHD) is a common medical problem worldwide that demands shared care of general practitioners and cardiologists for concerned patients. In order to improve the cooperation between both medical specialists and to optimize evidence-based care, a treatment pathway for patients with CHD was developed and evaluated in a feasibility study according to the recommendation for the development and evaluation of complex interventions of the British Medical Research Council (MRC). In the context of this feasibility study the objective of the present research was to investigate the contributions of different disease related (e.g. prior myocardial infarction), pathway related (e.g. basic medication) and demographic variables on patients` perceived health related quality of life (HRQoL) as a relevant and widely used outcome measure in cardiac populations.

METHODS

Data assessing demographic, disease and pathway related variables of CHD patients included in the study were collected in a quasi-experimental design with three study arms (pathway developers, users, control group) via case record forms and questionnaires at baseline and after 6 and 12 (intervention groups), and 9 months (control group), respectively after the initial implementation on GP level. Additionally, at the same measuring points the CHD patients participating in the study were interviewed by phone regarding their perceived HRQoL, measured with the EuroQol EQ-5D as an index-based health questionnaire. Due to the hierarchical structure of the data, we performed cross-sectional and longitudinal linear mixed models to investigate the impact of disease related, pathway related and demographic variables on patients` perceived HRQoL.

RESULTS

Of 334 initially recruited patients with CHD, a total of 290 were included in our analysis. This was an average 13.2% dropout rate from baseline assessment to the 12-month follow-up. At all assessment points, patients` HRQoL was associated with a variety of sociodemographic variables (e.g. gender, employment, education) in each study group, but there was no association with pathway related variables. In both cross-sectional and longitudinal analyses highest HRQoL values in patients were reported in the physician group that had developed the pathway. In the longitudinal analyses there were no significant changes in the reported HRQoL values of the three groups over time.

CONCLUSIONS

The found associations between sociodemographic variables and the perceived HRQoL of patients with CHD are in line with other research. As there are no associations of HRQoL with pathway related variables like the basic medication, possible weaknesses in the study design or the choice of outcome have to be considered before planning and conducting an evaluation study according to the MRC recommendations. Additionally, as patients in the developer group reported the highest HRQoL values over time, a higher commitment of the GPs in the developer group can be assumed and should be considered in further research.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/626e/3464887/828099dc3da5/1477-7525-10-78-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/626e/3464887/b0a0b6961a1e/1477-7525-10-78-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/626e/3464887/0335615e4283/1477-7525-10-78-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/626e/3464887/828099dc3da5/1477-7525-10-78-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/626e/3464887/b0a0b6961a1e/1477-7525-10-78-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/626e/3464887/0335615e4283/1477-7525-10-78-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/626e/3464887/828099dc3da5/1477-7525-10-78-3.jpg
摘要

背景

冠心病(CHD)是一种常见的全球性医学问题,需要全科医生和心脏病专家共同关注患者。为了改善这两个医学专业之间的合作,并优化基于证据的护理,根据英国医学研究理事会(MRC)制定和评估复杂干预措施的建议,制定了冠心病患者的治疗途径,并在一项可行性研究中进行了评估。在这项可行性研究的背景下,本研究的目的是调查不同疾病相关(例如先前的心肌梗死)、途径相关(例如基本药物)和人口统计学变量对患者感知的健康相关生活质量(HRQoL)的贡献,因为 HRQoL 是心脏人群中常用的一种相关结果测量。

方法

通过病例记录表格和问卷,在一个准实验设计中,在三个研究组(途径开发者、使用者、对照组)中收集了包括在研究中的冠心病患者的人口统计学、疾病和途径相关变量的数据,基线和 6 个月和 12 个月(干预组),以及 9 个月(对照组)后,GP 级别的初始实施后分别进行了评估。此外,在同一测量点,研究中的冠心病患者通过电话接受了他们感知的 HRQoL 的访谈,使用 EuroQol EQ-5D 作为基于索引的健康问卷进行测量。由于数据的层次结构,我们进行了横断面和纵向线性混合模型分析,以调查疾病相关、途径相关和人口统计学变量对患者感知 HRQoL 的影响。

结果

在最初招募的 334 名冠心病患者中,共有 290 名患者纳入了我们的分析。从基线评估到 12 个月随访,这是一个平均 13.2%的失访率。在所有评估点,患者的 HRQoL 与各研究组的各种社会人口统计学变量(例如性别、就业、教育)相关,但与途径相关变量无关。在横断面和纵向分析中,在制定途径的医生组中,患者报告的 HRQoL 值最高。在纵向分析中,三组的报告 HRQoL 值在整个研究过程中没有随时间显著变化。

结论

与冠心病患者感知的 HRQoL 相关的社会人口统计学变量的发现关联与其他研究一致。由于 HRQoL 与基本药物等途径相关变量无关,因此在根据 MRC 建议进行规划和开展评估研究之前,必须考虑研究设计或结果选择的可能弱点。此外,由于开发人员组中的患者随着时间的推移报告了最高的 HRQoL 值,因此可以假设全科医生在开发人员组中的承诺更高,应在进一步的研究中考虑这一点。

相似文献

1
Associations between demographic, disease related, and treatment pathway related variables and health related quality of life in primary care patients with coronary heart disease.冠心病初级保健患者的人口统计学、疾病相关和治疗途径相关变量与健康相关生活质量之间的关联。
Health Qual Life Outcomes. 2012 Jul 9;10:78. doi: 10.1186/1477-7525-10-78.
2
Secondary prevention in patients with coronary heart diseases: what factors are associated with health status in usual primary care?冠心病患者的二级预防:哪些因素与常规初级保健中的健康状况相关?
PLoS One. 2012;7(12):e51726. doi: 10.1371/journal.pone.0051726. Epub 2012 Dec 26.
3
Cardiac self-efficacy and quality of life in patients with coronary heart disease: a cross-sectional study from Palestine.冠心病患者的心脏自我效能量表和生活质量:来自巴勒斯坦的一项横断面研究。
BMC Cardiovasc Disord. 2019 Dec 13;19(1):290. doi: 10.1186/s12872-019-01281-7.
4
Profile and Correlates of Health-related Quality of Life in Chinese Patients with Coronary Heart Disease.中国冠心病患者健康相关生活质量的概况及相关因素
Chin Med J (Engl). 2015 Jul 20;128(14):1853-61. doi: 10.4103/0366-6999.160486.
5
Psychological distress mediates the effects of socio-demographic and clinical characteristics on the physical health component of health-related quality of life in patients with coronary heart disease.心理困扰介导了社会人口学和临床特征对冠心病患者健康相关生活质量的身体健康组成部分的影响。
Eur J Prev Cardiol. 2014 Jan;21(1):107-16. doi: 10.1177/2047487312451541. Epub 2012 Jun 7.
6
Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.验证痴呆症患者健康相关生活质量专用指标原型的研究。
Health Qual Life Outcomes. 2012 Sep 25;10:118. doi: 10.1186/1477-7525-10-118.
7
Qualitative evaluation of a local coronary heart disease treatment pathway: practical implications and theoretical framework.定性评估局部冠心病治疗路径:实际意义和理论框架。
BMC Fam Pract. 2012 May 14;13:36. doi: 10.1186/1471-2296-13-36.
8
Association between physical inactivity and health-related quality of life in adults with coronary heart disease.体力活动不足与冠心病成年人健康相关生活质量的关系。
Maturitas. 2019 Oct;128:36-42. doi: 10.1016/j.maturitas.2019.07.005. Epub 2019 Jul 11.
9
Assessment of perceived health status among primary care patients in Southern Italy: findings from a cross-sectional survey.意大利南部初级保健患者感知健康状况评估:一项横断面调查的结果。
Health Qual Life Outcomes. 2013 Jun 10;11:93. doi: 10.1186/1477-7525-11-93.
10
A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.采用 EQ-5D 对中国慢性丙型肝炎病毒感染患者的健康相关生命质量进行横断面评估。
Health Qual Life Outcomes. 2018 Jun 15;16(1):124. doi: 10.1186/s12955-018-0941-8.

引用本文的文献

1
The Associations Between Patients' Characteristics and the Quality of Life Among Acute Coronary Syndrome Patients in Jordan: A Cross-Sectional Study.约旦急性冠状动脉综合征患者的特征与生活质量之间的关联:一项横断面研究。
SAGE Open Nurs. 2022 Sep 28;8:23779608221129129. doi: 10.1177/23779608221129129. eCollection 2022 Jan-Dec.
2
Methodology of the health economic evaluation of the Feel4Diabetes-study.Feel4Diabetes 研究的健康经济评价方法。
BMC Endocr Disord. 2020 Mar 12;20(Suppl 1):14. doi: 10.1186/s12902-019-0471-3.
3
The Likert scale is a powerful tool for quality of life assessment among patients after minimally invasive coronary surgery.

本文引用的文献

1
Qualitative evaluation of a local coronary heart disease treatment pathway: practical implications and theoretical framework.定性评估局部冠心病治疗路径:实际意义和理论框架。
BMC Fam Pract. 2012 May 14;13:36. doi: 10.1186/1471-2296-13-36.
2
Health-related quality of life is associated with positive affect in patients with coronary heart disease entering cardiac rehabilitation.冠心病患者进入心脏康复阶段后,与健康相关的生活质量与积极情绪相关。
J Clin Psychol Med Settings. 2013 Mar;20(1):79-87. doi: 10.1007/s10880-012-9311-6.
3
Gender differences and determinants of health related quality of life in coronary patients: a follow-up study.
李克特量表是评估微创冠状动脉手术后患者生活质量的有力工具。
Kardiochir Torakochirurgia Pol. 2018 Jun;15(2):130-134. doi: 10.5114/kitp.2018.76480. Epub 2018 Jun 25.
4
Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis.美国心肌梗死幸存者的健康相关生活质量:倾向评分匹配分析。
Health Qual Life Outcomes. 2017 Dec 4;15(1):235. doi: 10.1186/s12955-017-0809-3.
5
Comorbidities and characteristics of coronary heart disease patients: their impact on health-related quality of life.冠心病患者的合并症及特征:它们对健康相关生活质量的影响。
Health Qual Life Outcomes. 2016 Nov 15;14(1):159. doi: 10.1186/s12955-016-0560-1.
6
Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart Disease.冠心病基于偏好的生活质量值的多变量荟萃分析
PLoS One. 2016 Mar 24;11(3):e0152030. doi: 10.1371/journal.pone.0152030. eCollection 2016.
7
Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability Theory.发展和验证冠心病量表在慢性病生活质量工具系统 QLICD-CHD 下:经典测试理论和概化理论的结合。
Health Qual Life Outcomes. 2014 Jun 4;12:82. doi: 10.1186/1477-7525-12-82.
8
Health-related quality of life and socioeconomic status: inequalities among adults with a chronic disease.健康相关生活质量和社会经济地位:慢性病成年人中的不平等。
Health Qual Life Outcomes. 2014 Apr 25;12:58. doi: 10.1186/1477-7525-12-58.
冠心病患者健康相关生活质量的性别差异及决定因素:一项随访研究。
BMC Cardiovasc Disord. 2011 May 27;11:24. doi: 10.1186/1471-2261-11-24.
4
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD004816. doi: 10.1002/14651858.CD004816.pub4.
5
EuroQol (EQ-5D) health utility scores for patients with migraine.偏头痛患者的欧洲五维健康量表(EQ-5D)健康效用评分。
Qual Life Res. 2011 May;20(4):601-8. doi: 10.1007/s11136-010-9783-5. Epub 2010 Nov 10.
6
Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008.中国人口健康状况:2008 年国家卫生服务调查按年龄、性别和社会经济地位划分的 EQ-5D 结果。
Qual Life Res. 2011 Apr;20(3):309-20. doi: 10.1007/s11136-010-9762-x. Epub 2010 Nov 2.
7
Employment is associated with the health-related quality of life of morbidly obese persons.就业与病态肥胖人群的健康相关生活质量有关。
Obes Surg. 2011 Nov;21(11):1704-9. doi: 10.1007/s11695-010-0289-6.
8
Satisfaction of patients and primary care physicians with shared decision making.患者和初级保健医生对共同决策的满意度。
Eval Health Prof. 2010 Sep;33(3):321-42. doi: 10.1177/0163278710376662.
9
Impact and characteristics of quality of life in Japanese patients with multiple sclerosis.多发性硬化症日本患者的生活质量影响及其特征。
Qual Life Res. 2011 Feb;20(1):119-31. doi: 10.1007/s11136-010-9725-2. Epub 2010 Aug 11.
10
What is a clinical pathway? Development of a definition to inform the debate.什么是临床路径?一个定义的发展,以提供信息的辩论。
BMC Med. 2010 May 27;8:31. doi: 10.1186/1741-7015-8-31.